0001140361-23-050619.txt : 20231101
0001140361-23-050619.hdr.sgml : 20231101
20231101061533
ACCESSION NUMBER: 0001140361-23-050619
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231031
FILED AS OF DATE: 20231101
DATE AS OF CHANGE: 20231101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eastling Thomas Wilson
CENTRAL INDEX KEY: 0001958487
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 231366448
MAIL ADDRESS:
STREET 1: 17520 HIGH BLUFF DRIVE
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GYRE THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001124105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562020050
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 650-266-8674
MAIL ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST BIOSCIENCES, INC.
DATE OF NAME CHANGE: 20150820
FORMER COMPANY:
FORMER CONFORMED NAME: TARGACEPT INC
DATE OF NAME CHANGE: 20000919
4
1
form4.xml
X0508
4
2023-10-31
0001124105
GYRE THERAPEUTICS, INC.
GYRE
0001958487
Eastling Thomas Wilson
C/O GYRE THERAPEUTICS, INC.
12730 HIGH BLUFF DRIVE, SUITE 250
SAN DIEGO
CA
92130
true
false
Stock Option (Right to Buy)
6.93
2023-10-31
4
A
0
314652
0
A
2033-10-31
Common Stock
314652
314652
D
Stock Option (Right to Buy)
6.93
2023-10-31
4
A
0
1866
0
A
2033-10-31
Common Stock
1866
1866
D
These options are vested in full.
These options vest as to one-third on each of the first, second and third anniversaries of October 31, 2023, subject to the Reporting Person's continued service to the Issuer through each vesting date.
/s/ Ruoyu Chen, as attorney-in-fact for Thomas Eastling
2023-11-01